Physician profile
George E Dailey
NPI 1841266343
$22,631.42
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,978 · 2021: $21.33 · 2022: $20.71.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $11,000.00 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,827.31 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $458.31 | 2019-2020 | |
| Insulet Corporation | $136.98 | 2019-2020 | |
| Lilly USA, LLC | $134.50 | 2019-2020 | |
| Abbvie INC. | $127.91 | 2019-2020 | |
| Eli Lilly and Company | $96.23 | 2019 | |
| Tandem Diabetes Care, INC. | $81.85 | 2019-2020 | |
| Antares Pharma, INC. | $76.98 | 2019-2020 | |
| Corcept Therapeutics | $76.45 | 2019-2020 | |
| Abbott Laboratories | $59.60 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $56.23 | 2019-2020 | |
| Amgen INC. | $50.32 | 2019 | |
| Allergan, INC. | $44.01 | 2019 | |
| Alexion Pharmaceuticals, INC. | $43.34 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $42.13 | 2019-2020 | |
| Philips North America LLC | $40.89 | 2019 | |
| Insmed, INC. | $39.45 | 2019-2020 | |
| Horizon Therapeutics Plc | $37.15 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $35.91 | 2019 | |
| Dexcom, INC. | $28.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $25.46 | 2019 | |
| United Therapeutics Corporation | $21.00 | 2019 | |
| Radius Health, INC. | $20.95 | 2019 | |
| Senseonics, Incorporated | $20.00 | 2020 | |
| Shire North American Group INC | $18.94 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.38 | 2019 | |
| Electromed, INC. | $12.93 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Research and ownership
$1,714.70 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Dailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.